Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody

Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic of novel coronavirus disease (COVID-19). Though vaccines and neutralizing monoclonal antibodies (mAbs) have been developed to fight COVID-19 in the past year, one major concern is the emergence of SARS-CoV-...

Full description

Bibliographic Details
Main Authors: Shuai Yue, Zhirong Li, Yao Lin, Yang Yang, Mengqi Yuan, Zhiwei Pan, Li Hu, Leiqiong Gao, Jing Zhou, Jianfang Tang, Yifei Wang, Qin Tian, Yaxing Hao, Juan Wang, Qizhao Huang, Lifan Xu, Bo Zhu, Pinghuang Liu, Kai Deng, Li Wang, Lilin Ye, Xiangyu Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
COVID-19
SARS-CoV-2 variants
neutralizing mAb
convalescent sera
antibody response
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.751584/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.751584/full

Similar Items